Background We aimed to accurately estimate the frequency of a hexanucleotide repeat
expansion in C9orf72 that has been associated with a large proportion of cases of amyotrophic …

To identify novel genes associated with ALS, we undertook two lines of investigation. We
carried out a genome-wide association study comparing 20,806 ALS cases and 59,804 controls…

BACE1 (beta-site amyloid precursor protein cleaving enzyme 1) was initially cloned and
characterized in 1999. It is required for the generation of all monomeric forms of amyloid-β (Aβ), …

Neuroinflammation commences decades before Alzheimer's disease (AD) clinical onset and
represents one of the earliest pathomechanistic alterations throughout the AD continuum. …

A large hexanucleotide (GGGGCC) repeat expansion in the first intron of C9ORF72, a gene
located on chromosome 9p21, has been recently reported to be responsible for ∼40% of …

We have compared the immunolocalization of neurofilament protein (NF) with two other
ncuronal-specific intermediate filament proteins in large spinal axonal swellings (spheroids) of …

Alzheimer’s disease (AD) is characterized by non-linear, genetic-driven pathophysiological
dynamics with high heterogeneity in biological alterations and disease spatial-temporal …

Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neurodegenerative disease
caused by the degeneration of motor neurons. The burden for ALS caregivers is quite high. …

Identification of mutations at familial loci for amyotrophic lateral sclerosis (ALS) has provided
novel insights into the aetiology of this rapidly progressing fatal neurodegenerative disease. …

Background Amyotrophic lateral sclerosis (ALS) is a fatal progressive motor neuron disease,
for which there are still no diagnostic/prognostic test and therapy. Specific molecular …